Mounjaro or Saxenda? An Honest Comparison (2026)
These two come up side by side all the time, and it’s easy to feel stuck choosing between them. We’ve laid out how Mounjaro and Saxenda differ on the things that actually shape your day-to-day — results, cost, how you take them, and how they tend to feel — so you can head into your next appointment with a clear question instead of a guess.
The quick answer
In short: Mounjaro (Tirzepatide) helps people lose around 15–22% of their body weight at roughly $1,023/mo, while Saxenda (Liraglutide) averages about 5–10% at roughly $1,349/mo. Neither is a clear winner for everyone — what tips the scale is your goals, what your insurance covers, and how your body takes to it.
The two, side by side
| Feature | Mounjaro | Saxenda |
|---|---|---|
| Active ingredient | Tirzepatide | Liraglutide |
| Drug class | Dual GLP-1/GIP receptor agonist | GLP-1 receptor agonist |
| Manufacturer | Eli Lilly | Novo Nordisk |
| FDA approved for | Type 2 diabetes | Chronic weight management |
| Approval year | 2022 | 2014 |
| Doses | 2.5, 5, 7.5, 10, 12.5, 15 mg | 0.6mg to 3.0mg daily |
| Administration | Weekly injection (pen) | Daily injection (pen) |
| Avg. weight loss | 15–22% | 5–10% |
| A1C reduction | 1.9–2.4% | 1.0–1.3% |
| Monthly cost (list) | $1,023 | $1,349 |
| Oral available | No | No |
Prices shown are typical self-pay list costs without insurance. Seed data — please verify before relying on it.
Mounjaro
15–22%
avg. body-weight loss
A weekly tirzepatide shot for type 2 diabetes that works on two hunger pathways at once, which is why trial participants tend to see some of the biggest average weight loss of any option.
$1,023/mo list price
Saxenda
5–10%
avg. body-weight loss
One of the earlier weight-management GLP-1s, taken as a daily injection. It still works, but most people now choose a once-a-week option instead of injecting every day.
$1,349/mo list price
Mounjaro might be your match if…
- Your plan covers it but not Saxenda — let coverage lead.
- A longer track record puts you at ease (it’s been around since 2022).
- You’re already doing well on Tirzepatide and would rather not switch.
Saxenda might be your match if…
- The strongest possible weight loss is your top priority (5–10%).
- You’re drawn to its glp-1 receptor agonist approach.
- Your plan covers Saxenda (or its weight-loss version).
Let’s find the right program for you
We’ll show you the vetted telehealth programs that can prescribe these medications, so the next step is easy.
Questions people ask us about these two
Not sure which program is the right fit?
Answer six quick questions and we'll point you to the programs that suit your budget, your insurance, and how you want to be cared for.